SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-18-000084
Filing Date
2018-09-06
Accepted
2018-09-05 20:44:22
Documents
15
Period of Report
2018-09-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cti-item5028xk.htm 8-K 33326
2 EXHIBIT 1 ctijacksingerseparationa.htm EX-1 62651
3 ctijacksingerseparationa001.jpg GRAPHIC 254042
4 ctijacksingerseparationa002.jpg GRAPHIC 292305
5 ctijacksingerseparationa003.jpg GRAPHIC 304372
6 ctijacksingerseparationa004.jpg GRAPHIC 299968
7 ctijacksingerseparationa005.jpg GRAPHIC 338991
8 ctijacksingerseparationa006.jpg GRAPHIC 343200
9 ctijacksingerseparationa007.jpg GRAPHIC 336936
10 ctijacksingerseparationa008.jpg GRAPHIC 285867
11 ctijacksingerseparationa009.jpg GRAPHIC 40258
12 ctijacksingerseparationa010.jpg GRAPHIC 38382
13 ctijacksingerseparationa011.jpg GRAPHIC 15985
14 ctijacksingerseparationa012.jpg GRAPHIC 136250
15 ctijacksingerseparationa013.jpg GRAPHIC 84898
  Complete submission text file 0000891293-18-000084.txt   3916184
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 181056516
SIC: 2834 Pharmaceutical Preparations